COLUMBUS, Ohio – The Ohio State University College of Medicine increased its funding from the National Institutes of Health (NIH) to $138 million in 2019 — up $37 million over the previous year. The annual analysis compiled by Blue Ridge Institute for Medical Research, which includes research and development contracts from the NIH, ranked Ohio State No. 42 overall.
With 26 clinical and basic science departments, along with 18 colleges and schools across campus, Ohio State is uniquely positioned for collaboration and team science. “We continue to significantly grow research funding year-over-year,” explains Peter Mohler, PhD, vice dean for Research at the Ohio State College of Medicine. “Our strategic focus is to become a Top 20 medical school and we are well on our way. At Ohio State, we look to make advancements in gene therapy, neuro, psychiatry and immunology, among others, to develop solutions that will transform the health of people around the world.”
Four of the college’s research programs boast top 20 rankings:
- Surgery, No. 5 with $15.5 million
- Physiology, No. 9 with $12.5 million
- Emergency Medicine, No. 14 with $1.4 million
- Otolaryngology, No. 18 with $2.6 million
In addition, Ohio State had strong upward movement in Internal Medicine, Neurology, Neurosurgery and Ophthalmology. The NIH is the largest public funder of biomedical research in the world, supporting research and training the next generation of research investigators.